Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial
Titel:
Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial
Auteur:
Barcenas, C.H. Hurvitz, S.A. Di Palma, J.A. Bose, R. Chien, A.J. Iannotti, N. Marx, G. Brufsky, A. Litvak, A. Ibrahim, E. Alvarez, R.H. Ruiz-Borrego, M. Chan, N. Manalo, Y. Kellum, A. Trudeau, M. Thirlwell, M. Garcia Saenz, J. Hunt, D. Bryce, R. McCulloch, L. Rugo, H.S. Tripathy, D. Chan, A.